We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Andor Tech | AND | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 509.75 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 509.75 |
| Top Posts |
|---|
Posted at 12/11/2013 09:29 by alter ego I was thinking the absence of an RNS from Andor might suggest the OXIG were trying to put pressure on a reluctant BOD by going public. This looks to be the case now that AND have rushed out a response.It especially irritating for me as a long term holder in AND where I see a good future and where I was on the point of buying OXIG in the next few days given the steady downward drift which was making them look good value. Now OXIG has soared as it looks like investors think they would be getting a very good deal. Not what I hoped for. |
Posted at 08/6/2012 08:12 by battlebus2 PW i've heard your negative comments on various bulletin boards but i have to say that statement has to be your stupidest. Do us a favour and don't come back till we are trading in pennies. Druinsky that was before it had established itself into the current business. As essential investor said we all knew they were suffering a sales decline in the USA but this is temporary and staff have been dispatched to rectify the problem. As ever this will take time. Meantime a buy now should reward in time imv. |
Posted at 22/4/2012 13:09 by protean battlebus2 - it looks as if that article is from 2011 and last year's Master Investor conference. |
Posted at 05/11/2010 06:41 by kimball808 Tis a pleasure, There is a bloke (investor) who writes in the weekend FT (Can't remember his name) that is always referring to his rare coin collection as part of his portfolio which is doing very well..GL |
Posted at 04/6/2006 11:57 by tole Nice spot - full article below. ;)Sharewatch: Profits put the focus on Andor Edited by Joe Brennan THE physicists at Queen's University Belfast who founded Andor Technology could scarcely believe their eyes when the stock soared 40% on its first day of trading in December 2004. Since then, however, shares in the maker of the world's most sensitive digital cameras have been something of a disappointment. It didn't help that the company issued a profit warning last August due to costs related to its new facility in Belfast. Andor sells its sophisticated cameras in the fields of drug discovery, medical diagnosis, defence, food-quality testing, space and surveillance. Recently, the group unveiled operating profits of £654,000 (952,923) for the six months to the end of March, up 124% on the same period last year, as sales increased by 23% to £9.2m. Goodbody Stockbrokers upgraded its rating on the stock to "buy", saying: "We foresee 162% growth in earnings per share over the next three years; the shares are trading at a price-to-earnings discount to the peer group; and there are realistic prospects of earnings upgrades going forward." With the broker's price target of £1.30 on the stock implying some 30% upside from its closing price on Friday, it might only be a matter of time before investors zoom in on this one. |
Posted at 03/12/2004 10:05 by choppa New admission. Like the average revenue and EBITA growth over the last few years. Any comments?RNS Number:9797F Andor Technology plc 03 December 2004 3 December 2004 Andor Technology PLC Admission to AIM - First Day of Dealings Andor Technology PLC ("Andor" or "the Company"), a developer and manufacturer of high performance digital cameras and their associated products, today announces its Admission to AIM and the commencement of dealings in its Ordinary Shares. Highlights: * The Company has raised approximately #4.5 million (before expenses) through a placing of 5,015,643 shares at 90 pence per share. * On admission, the Company has a market capitalisation of approximately #23 million. * In addition, the Company's existing institutional backers have placed 4,145,865 shares, raising approximately #3.7 million. * The placing shares have been placed with institutional investors, including venture capital trusts, by Bridgewell, which will act as nominated adviser and broker to the Company. * The net proceeds of the Placing will be used by the Company to accelerate research and development, to purchase capital equipment that will increase automation of the company's production process, to develop new sales channels for Andor and to redeem certain preference shares. Note: Included in the above statistics are 1,126,754 shares for which application has been made for admission to trading on AIM on 6 December 2004. Andor is a Belfast-based firm which operates at the high-value end of the $38.6bn global digital camera market was set up in 1989 as an incubation business at Queens University Belfast. In 2001, private equity firm Legal Development Capital provided significant development capital to help increase production capacity and assist the firm's entry into new markets. Andor now employs 145 people and distributes its products to customers in at least 29 countries worldwide. Andor develops and manufactures a range of high performance digital cameras and their associated products used for the measurement of light. Today Andor has a portfolio of over 70 products which are employed in fields as diverse as drug discovery, toxicology analysis, medical diagnosis, food quality testing and defence. Thanks to new techniques developed by Andor scientists, Andor cameras can measure light down to just one photon and can also measure light occurring in very short time resolutions - within 1 billionth of a second. The management team at Andor have carved out a long track record of growth and profitability for the company, reporting a profit before tax in each of the last 6 years of operations. The average annual revenue growth rate during the period of 1999-2004 is 32.9%, whilst the comparative EBIT growth rate figure is 53%. Remarking on the Admission, Dr Hugh Cormican, Andor Chief Executive said: "We are delighted to be joining AIM today and our Admission represents a critical step in the continued development of our company. This listing will raise the equity funds necessary for us to accelerate the Company's strategic aims and will also raise Andor's profile among suppliers and both existing and potential new customers. We look forward to developing Andor as a listed company and are pleased to welcome our new shareholders on board." Commenting on the news, Andor Non-Executive Chairman Dr Bryan Keating said: "We have an excellent product line at Andor, backed by a strong team and a robust business model. Today's admission to AIM is a significant step forward for our company - and a clear reminder of the real innovations taking place in Northern Ireland's universities and private sector." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
